Results 21 to 30 of about 1,394,911 (165)
Thrombopoietin Receptor Agonists for Treatment Thrombocytopenia in Dengue Fever [PDF]
, 2023 Dengue fever is considered to be the most prevalent mosquito - borne viral disease worldwide and has proven to be life - threatening at times. Thrombocytopenia occurs in mild and severe cases of dengue fever. commonly observed.
Sisilia, Adelina
core +2 more sources
Treatment preferences towards thrombopoietin-receptor agonists for immune thrombocytopenia and experience of disease (TRAPeze): Italy cohort [PDF]
, 2023 Identify patient preference towards thrombopoietin-receptor agonists (TPO-RAs) and determine the clinical and social impact of immune thrombocytopenia (ITP) in Italy.
Emma Geldman (11876937) +12 more
core +2 more sources
, 2023 Supplemental material, sj-pdf-1-opp-10.1177_10781552231219003 for Role of thrombopoietin receptor agonists in chemotherapy-induced thrombocytopenia: A meta-analysis by Gerard Gurumurthy, Filip Kisiel, Samantha Gurumurthy and Juditha Gurumurthy in Journal
Filip Kisiel (17711543) +3 more
core +1 more source
CiD agonists: Circular DNA-based agonists for the fine-tuning of receptor signaling [PDF]
, 2022 Receptor dimerization geometry plays a significant role in signal transduction induced by growth factors and cytokines. A chemical strategy capable of controlling dimerization geometry provides a means for studying receptor activation mechanisms and ...
Momoko , Akiyama +9 more
core +2 more sources
, 2021 Immune thrombocytopenia (ITP) is an autoimmune disease characterized by low platelet count and increased bleeding risk. Treatment with thrombopoietin receptor agonists (TPO-RAs) is effective in increasing platelet count, however, an increase in ...
Garabet, Lamya
core +1 more source
Regulation of thrombopoietin receptor expression and function [PDF]
, 2004 Of the many cells in the body, the hematopoietic cells are among those with the highest rate of self-renewal and turnover. The production and destruction of these cells are tightly controlled by a number of hematopoietic growth factors, in particular by ...
Coers, Jörn
core +1 more source
Thrombopoietin Receptor Agonists in Children With Immune Thrombocytopenia: A New Therapeutic Era
, 2021 Background and objective: Immune thrombocytopenia (ITP) is a common bleeding disorder in child-hood. The management of ITP in children is controversial, requiring personalized assessment of patients and therapeutic choices.
Giovanni Carlo Del Vecchio +6 more
core +1 more source
Highly potent, selective acylguanidine-type histamine H2 receptor agonists: synthesis and structure-activity relationships [PDF]
, 2008 Potent and selective histamine H2 receptor (H2R) agonists are valuable pharmacological tools and might be of therapeutic value as drugs, for example in the treatment of severe congestive heart failure.
Kraus, Anja
core +1 more source
Risk of thrombosis with thrombopoietin receptor agonists for ITP patients:A review and meta [PDF]
, 2022 One possible side effect of thrombopoietin receptor agonists in immune thrombocytopenia is thrombosis. Our aim is to systematically review whether patients with ITP that were treated with a TPO-RA have an increased risk for thrombosis as compared to ITP ...
Tjepkema, M. +8 more
core +1 more source
Medicina, 2023 Primary immune thrombocytopenia (ITP) is an acquired blood disorder that causes a reduction in circulating platelets with the potential for bleeding. The incidence of ITP is slightly higher in adults and affects more women than men until 60 years, when ...
Tomás José González-López +2 more
doaj +1 more source